Free Trial

Corbus Pharmaceuticals (CRBP) Stock Price, News & Analysis

Corbus Pharmaceuticals logo
$7.30 -0.41 (-5.32%)
As of 04:00 PM Eastern

About Corbus Pharmaceuticals Stock (NASDAQ:CRBP)

Key Stats

Today's Range
$7.26
$7.68
50-Day Range
$6.16
$9.24
52-Week Range
$4.64
$61.90
Volume
86,260 shs
Average Volume
203,744 shs
Market Capitalization
$89.35 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$50.88
Consensus Rating
Buy

Company Overview

Corbus Pharmaceuticals Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
76th Percentile Overall Score

CRBP MarketRank™: 

Corbus Pharmaceuticals scored higher than 76% of companies evaluated by MarketBeat, and ranked 241st out of 913 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Corbus Pharmaceuticals has received a consensus rating of Buy. The company's average rating score is 3.10, and is based on 9 buy ratings, no hold ratings, and no sell ratings.

  • Amount of Analyst Coverage

    Corbus Pharmaceuticals has only been the subject of 4 research reports in the past 90 days.

  • Read more about Corbus Pharmaceuticals' stock forecast and price target.
  • Earnings Growth

    Earnings for Corbus Pharmaceuticals are expected to decrease in the coming year, from ($4.23) to ($6.29) per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Corbus Pharmaceuticals is -1.73, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Corbus Pharmaceuticals is -1.73, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Book Value per Share Ratio

    Corbus Pharmaceuticals has a P/B Ratio of 0.63. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.

  • Read more about Corbus Pharmaceuticals' valuation and earnings.
  • Percentage of Shares Shorted

    17.48% of the float of Corbus Pharmaceuticals has been sold short.
  • Short Interest Ratio / Days to Cover

    Corbus Pharmaceuticals has a short interest ratio ("days to cover") of 12.2, which indicates bearish sentiment.
  • Change versus previous month

    Short interest in Corbus Pharmaceuticals has recently increased by 2.19%, indicating that investor sentiment is decreasing.
  • Dividend Yield

    Corbus Pharmaceuticals does not currently pay a dividend.

  • Dividend Growth

    Corbus Pharmaceuticals does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    17.48% of the float of Corbus Pharmaceuticals has been sold short.
  • Short Interest Ratio / Days to Cover

    Corbus Pharmaceuticals has a short interest ratio ("days to cover") of 12.2, which indicates bearish sentiment.
  • Change versus previous month

    Short interest in Corbus Pharmaceuticals has recently increased by 2.19%, indicating that investor sentiment is decreasing.
  • News Sentiment

    Corbus Pharmaceuticals has a news sentiment score of 0.30. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.57 average news sentiment score of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 3 news articles for Corbus Pharmaceuticals this week, compared to 3 articles on an average week.
  • Search Interest

    Only 1 people have searched for CRBP on MarketBeat in the last 30 days. This is a decrease of -75% compared to the previous 30 days.
  • MarketBeat Follows

    Only 3 people have added Corbus Pharmaceuticals to their MarketBeat watchlist in the last 30 days. This is a decrease of -25% compared to the previous 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Corbus Pharmaceuticals insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $30,547.00 in company stock.

  • Percentage Held by Insiders

    Only 4.00% of the stock of Corbus Pharmaceuticals is held by insiders.

  • Percentage Held by Institutions

    64.64% of the stock of Corbus Pharmaceuticals is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

  • Read more about Corbus Pharmaceuticals' insider trading history.
Receive CRBP Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Corbus Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter.

CRBP Stock News Headlines

Here's the last trade you should make before heading out for the weekend tomorrow.
Make this one trade at 2:59 PM on Friday afternoon, and you'll thank me on Monday morning.
See More Headlines

CRBP Stock Analysis - Frequently Asked Questions

Corbus Pharmaceuticals' stock was trading at $11.80 at the start of the year. Since then, CRBP stock has decreased by 38.0% and is now trading at $7.32.

Corbus Pharmaceuticals Holdings, Inc. (NASDAQ:CRBP) issued its earnings results on Tuesday, May, 6th. The biopharmaceutical company reported ($1.39) EPS for the quarter, missing the consensus estimate of ($1.26) by $0.13.

Shares of CRBP stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Corbus Pharmaceuticals investors own include Visa (V), NVIDIA (NVDA), Meta Platforms (META), Advanced Micro Devices (AMD), Tesla (TSLA), Alibaba Group (BABA) and Pfizer (PFE).

Company Calendar

Last Earnings
5/06/2025
Today
7/07/2025
Next Earnings (Estimated)
8/05/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
MED - DRUGS
Sub-Industry
Pharmaceutical Products
Current Symbol
NASDAQ:CRBP
Employees
40
Year Founded
2009

Price Target and Rating

Average Stock Price Target
$50.88
High Stock Price Target
$74.00
Low Stock Price Target
$35.00
Potential Upside/Downside
+581.1%
Consensus Rating
Buy
Rating Score (0-4)
3.10
Research Coverage
10 Analysts

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$40.21 million
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A
Price / Cash Flow
N/A
Book Value
$11.69 per share
Price / Book
0.64

Miscellaneous

Free Float
11,748,000
Market Cap
$91.43 million
Optionable
Optionable
Beta
3.05

Social Links

The 10 Best AI Stocks to Own in 2025 Cover

Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.

Get This Free Report

This page (NASDAQ:CRBP) was last updated on 7/7/2025 by MarketBeat.com Staff
From Our Partners